Literature DB >> 12853099

Cancer of the larynx.

Lisa Licitra1, Jacques Bernier, Cesare Grandi, Laura Locati, Marco Merlano, Gemma Gatta, Jean-Louis Lefebvre.   

Abstract

In Europe, laryngeal cancer accounts for only 2-5% of all cancers, the incidence being much higher among males than among females. Smoke and alcohol represent the major behavioural risk factors. Several carcinogens, occupations and vitamin deficiencies have been associated with laryngeal cancer. A genetic susceptibility to environmental risk factors and carcinogens is recognized. Hoarseness is the main symptom for which patients call for medical consultation. Mucosa is the most common histologic site of the primary lesions considered in the present chapter. Nodal involvement, the site and volume of the primary tumour, and some genes expression represent the major prognostic factors. A high death rate for not cancer-related events is to be pointed out. The loco-regional extent of the disease determines the success of cure. Surgery and radiotherapy represent the main therapeutic options. The choice between these two procedures is often controversial.

Entities:  

Mesh:

Year:  2003        PMID: 12853099     DOI: 10.1016/s1040-8428(03)00017-9

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  22 in total

1.  Functional characterization of OPN in human laryngeal squamous cell carcinoma and its xenograft model in nude mice.

Authors:  Jianqiu Chen; Qi Zhou; Chunsheng Zhu; Minhui Zhu; Yongsheng Tian; Guojun Li; Xiaofeng Tao; Hongliang Zheng
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 2.  Conservative treatment for advanced T3-T4 laryngeal cancer: meta-analysis of key oncological outcomes.

Authors:  Giuditta Mannelli; Maria Silvia Lazio; Paolo Luparello; Oreste Gallo
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-11-08       Impact factor: 2.503

3.  l-DOPA Decarboxylase (DDC) Expression Status as a Novel Molecular Tumor Marker for Diagnostic and Prognostic Purposes in Laryngeal Cancer.

Authors:  Christos Patsis; Vasiliki Glyka; Ioannis Yiotakis; Emmanuel G Fragoulis; Andreas Scorilas
Journal:  Transl Oncol       Date:  2012-08-01       Impact factor: 4.243

4.  Factors predictive of outcome following primary total laryngectomy for advanced squamous cell carcinoma.

Authors:  Thomas F Pezier; Iain J Nixon; Anil Joshi; Teresa Guerrero-Urbano; Richard Oakley; Jean-Pierre Jeannon; Ricard Simo
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-10-23       Impact factor: 2.503

5.  Overexpression of osteopontin and integrin αv in laryngeal and hypopharyngeal carcinomas associated with differentiation and metastasis.

Authors:  Jian Guang Lu; Yong Li; Liang Li; Xuan Kan
Journal:  J Cancer Res Clin Oncol       Date:  2011-08-19       Impact factor: 4.553

6.  Association of OPN overexpression with tumor stage, differentiation, metastasis and tumor progression in human laryngeal squamous cell carcinoma.

Authors:  Jianqiu Chen; Chunsheng Zhu; Zhen He; Min Geng; Guojun Li; Xiaofeng Tao; Fenghua Zhang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

7.  The epidemiology of laryngeal cancer in a country on the esophageal cancer belt.

Authors:  Babak Saedi; Ebrahim Razmpa; Mohammad Sadeghi; Mohammad Mojtahed; Ali Mojtahed
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2009-09-27

8.  Sex hormone receptor levels in laryngeal carcinoma: a comparison between protein and RNA evaluations.

Authors:  Chiara Bianchini; Antonio Pastore; Stefano Pelucchi; Elena Torreggiani; Elisabetta Lambertini; Elena Marchesi; Eros Magri; Claudia Frasson; Patrizia Querzoli; Roberta Piva
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-02       Impact factor: 2.503

Review 9.  Predictive factors of neck metastases in laryngeal squamous cell carcinoma. Towards an integrated clinico-molecular classification.

Authors:  G Almadori; F Bussu; G Paludettii
Journal:  Acta Otorhinolaryngol Ital       Date:  2006-12       Impact factor: 2.124

10.  HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker?

Authors:  F Bussu; M Sali; R Gallus; V G Vellone; G F Zannoni; R Autorino; N Dinapoli; R Santangelo; R Martucci; C Graziani; F Miccichè; G Almadori; J Galli; G Delogu; M Sanguinetti; G Rindi; V Valentini; G Paludetti
Journal:  Br J Cancer       Date:  2013-02-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.